Expand+In Vivoiv.iiarjournals.orgIn Vivo September-October 2017 vol. 31 no. 5 925-930 Parathyroid Carcinoma in Patients that Have Undergone Surgery for Primary Hyperparathyroidism

Autor: Martina Fialová, Ondřej Naňka, Robert Lischke, Vladimir Bobek, Josef Kubinyi, Jiří Šedý, Adámek S, Broulík P, Pavel Pafko, P Libánský
Rok vydání: 2018
Předmět:
Zdroj: In Vivo. 31
ISSN: 1791-7549
Popis: BACKGROUND/AIM Parathyroid carcinoma is a rare clinical entity, which represents one of the main reasons, why surgery should be performed in specialized centres. Preoperatively, it is very difficult to distinguish between benign and malignant hyperparathyroidism. PATIENTS AND METHODS During the years 1996-2016, we performed 2,220 operations in 2,075 patients with a diagnosis of primary hyperparathyroidism. RESULTS Among these 2,220 operations, there were 16 operations for parathyroid carcinoma. These 16 operations, including reoperations, were performed in four patients. Two patients had no reoperation, but another 2 patients required 14 reoperations in total. Parathyroid carcinoma was described in 0.2% of all patients with a diagnosis of primary hyperparathyroidism. The number of operations was 0.73% of all operations of primary hyperparathyroidism in years 1996-2016. CONCLUSION Prognosis of parathyroid carcinoma is quite favourable, patients evidence a long-term survival rate after the primary operation. However, every reoperation increases the number of possible complications, including recurrent laryngeal nerve injury.
Databáze: OpenAIRE